This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioPharm America
2 days in-person. 2 days virtually.
September 28–29, 2022 | Boston, USAOctober 4–5, 2022 | Virtual

Solomon Babani
Senior Vice President at ICON


Mr Babani has 20+ years of drug development experience and is recognized across the industry for addressing partnering challenges biopharmaceutical companies encounter when building strategic relationships with CROs. At ICON, Mr Babani provides executive oversight across a broad portfolio of biotechnology and mid-size pharmaceutical sponsors. He brings a broad background to his role at ICON, having worked for pharmaceutical, biotechnology, and virtual drug development companies, as well as in academia. While at a private equity/virtual development company, Mr Babani managed a diverse portfolio of development programs and the associated relationships with their CROs and co-development partners. Most recently, Mr Babani served as vice president of alliance management at another CRO, where he developed and implemented a corporate-wide strategic initiative aimed at reengineering and expanding the company's engagement model with small pharmaceutical and biotechnology companies. He also led the company's global business development team focusing on providing customized drug development solutions to biopharmaceutical sponsors. Mr Babani holds a bachelor's degree in biology from Yeshiva University and a master's degree in business administration from New York University Stern School of Business.

Agenda Sessions

  • The R&D and Clinical Partnership Playbook